LPA and coronary artery disorder: In a study by Kaiser et al., involving 191 patients with ASCVD, it was found that high serum Lp(a) concentrations were associated with accelerated progression of low-attenuation plaque (necrotic core) in patients with advanced multivessel coronary artery disease, despite receiving guideline- based preventative therapies [17].